Good news on the vaccine development front. BioNTech and Pfizer study.
Early results in on this particular candidate. 24 of 24 volunteers developed higher neutralizing antibodies than that typically seen in infected people. Volunteers receiving the higher of doses tested did have some develop minor fevers, but nothing real serious.
Talking heads on CNBC were pointing out that this is Pfizer, not some volatile biotech company, meaning Pfizer has a history of being conservative when releasing positive results. Contrasting this with the Moderna debacle several weeks ago. Typically this info would get released until it has been peer reviewed/published, but like other COVID vaccine developments there is a desire to get the information out there so that other people can use the information.
|
Link: BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial
Posted: 07/01/2020 at 09:17AM